LOCAL CEREBRAL BLOOD-FLOW FOLLOWING THE INTRASTRIATAL ADMINISTRATION OF VASOACTIVE-INTESTINAL-PEPTIDE OR PEPTIDE HISTIDINE ISOLEUCINE IN THE RAT

被引:7
|
作者
TUOR, UI
EDVINSSON, L
KELLY, PAT
MCCULLOCH, J
机构
[1] UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[2] UNIV LUND HOSP,DEPT INTERNAL MED,S-22185 LUND,SWEDEN
[3] UNIV GLASGOW,WELLCOME SURG INST,GLASGOW G12 8QQ,SCOTLAND
基金
英国惠康基金;
关键词
Caudate nucleus; Cerebral circulation; Cerebral glucose utilization; Peptide histidine isoleucine; Vasoactive intestinal peptide;
D O I
10.1016/0167-0115(90)90023-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of the intrastriatal microinjection of either vasoactive intestinal peptide (VIP) or a related peptide - peptide histidine isoleucine (PHI) - on local cerebral blood flow in the striatum was examined using iodo[14C]antipyrine quantitative autoradiography. In 37 rats, an injection needle was inserted into a chronically implanted guide cannula and 1 μl of vehicle, VIP or PHI was injected into the striatum. Blood flow in sham controls was reduced by 15% in proximity to the injection site, when compared with blood flow in the contralateral unijected control side (P < 0.01). Similarly, following PHI administration (20 pmol), blood flow in the striatum was reduced by 14% when compared to that contralaterally (P < 0.02). In contrast, following VIP administration (20 pmol), blood flow in proximity to the injection site was increased compared to flow in the contralateral striatum in 4 8 animals with the mean flow being elevated by 10% (n.s.) compared to blood flow contralaterally. VIP and PHI had similar effects on local cerebral glucose utilization in the caudate nucleus, their response being equivalent to that of sham animals. These experiments suggest that VIP and PHI have a differential influence on the microvasculature of the caudate nucleus, with VIP but not PHI mediating cerebrovascular dilation. © 1990.
引用
收藏
页码:255 / 264
页数:10
相关论文
共 50 条
  • [41] DAY NIGHT VARIATION IN PREPRO VASOACTIVE INTESTINAL PEPTIDE PEPTIDE HISTIDINE ISOLEUCINE MESSENGER-RNA WITHIN THE RAT SUPRACHIASMATIC NUCLEUS
    ALBERS, HE
    STOPA, EG
    ZOELLER, RT
    KAUER, JS
    KING, JC
    FINK, JS
    MOBTAKER, H
    WOLFE, H
    MOLECULAR BRAIN RESEARCH, 1990, 7 (01): : 85 - 89
  • [42] MOLECULAR-FORMS OF PEPTIDE HISTIDINE ISOLEUCINE-LIKE IMMUNOREACTIVITY IN THE GASTROINTESTINAL-TRACT - NONEQUIMOLAR LEVELS OF PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE IN THE STOMACH EXPLAINED BY THE PRESENCE OF A BIG PEPTIDE HISTIDINE ISOLEUCINE-LIKE MOLECULEM
    YIANGOU, Y
    CHRISTOFIDES, ND
    BLANK, MA
    YANAIHARA, N
    TATEMOTO, K
    BISHOP, AE
    POLAK, JM
    BLOOM, SR
    GASTROENTEROLOGY, 1985, 89 (03) : 516 - 524
  • [43] GASTRIN, PEPTIDE HISTIDINE-METHIONINE (PHM), PEPTIDE YY (PYY), AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) IN TERM AND PRETERM MILK
    BERSETH, CL
    NORDYKE, CK
    MICHENER, SR
    GO, VLW
    PEDIATRIC RESEARCH, 1987, 21 (04) : A423 - A423
  • [44] PEPTIDE HISTIDINE METHIONINE AND VASOACTIVE-INTESTINAL-PEPTIDE - OCCURRENCE AND RELAXANT EFFECT IN THE HUMAN FEMALE REPRODUCTIVE-TRACT
    PALLE, C
    OTTESEN, B
    JORGENSEN, J
    FAHRENKRUG, J
    BIOLOGY OF REPRODUCTION, 1989, 41 (06) : 1103 - 1111
  • [45] COSECRETION OF PEPTIDE HISTIDINE METHIONINE (PHM) AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) IN PATIENTS WITH VIP-PRODUCING TUMORS
    FAHRENKRUG, J
    PEDERSEN, JH
    PEPTIDES, 1986, 7 (05) : 717 - 721
  • [46] VASOACTIVE-INTESTINAL-PEPTIDE FLUCTUATES IN HUMAN BLOOD WITH A CIRCADIAN-RHYTHM
    CUGINI, P
    LUCIA, P
    DIPALMA, L
    RE, M
    LEONE, G
    BATTISTI, P
    CANOVA, R
    GASBARRONE, L
    CIANETTI, A
    REGULATORY PEPTIDES, 1991, 34 (03) : 141 - 148
  • [47] ADMINISTRATION OF ANTISERA TO VASOACTIVE INTESTINAL POLYPEPTIDE AND PEPTIDE HISTIDINE ISOLEUCINE ATTENUATES ETHER-INDUCED PROLACTIN SECRETION IN RATS
    KAJI, H
    CHIHARA, K
    KITA, T
    KASHIO, Y
    OKIMURA, Y
    FUJITA, T
    NEUROENDOCRINOLOGY, 1985, 41 (06) : 529 - 531
  • [48] HEPATIC BILE FORMATION IN THE RAT - ADDITION OF VASOACTIVE-INTESTINAL-PEPTIDE TO THE EQUATION
    KNODELL, RG
    STEELE, NM
    STANLEY, LN
    DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (11) : 1290 - 1296
  • [49] VASOACTIVE-INTESTINAL-PEPTIDE ANTAGONIST RETARDS THE DEVELOPMENT OF NEONATAL BEHAVIORS IN THE RAT
    HILL, JM
    GOZES, I
    HILL, JL
    FRIDKIN, M
    BRENNEMAN, DE
    PEPTIDES, 1991, 12 (01) : 187 - 192
  • [50] LYMPHOID-CELL SUBPOPULATIONS CONTAINING VASOACTIVE-INTESTINAL-PEPTIDE IN THE RAT
    LECETA, J
    MARTINEZ, MC
    DELGADO, M
    GARRIDO, E
    GOMARIZ, RP
    PEPTIDES, 1994, 15 (05) : 791 - 797